Gas-Phase Cross-Linking with Ion/Ion Chemistry Coupled to Ion Mobility/Mass Spectrometry
离子/离子化学气相交联与离子淌度/质谱联用
基本信息
- 批准号:9807489
- 负责人:
- 金额:$ 20.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-01 至 2021-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY
Although many technologies exist for studying protein structures, none possess a combination of speed,
selectivity, accuracy, resolution, and flexibility. The long-term goal is to use a suite of gas-phase chemistries for
ion/ion reactions coupled to ion mobility (IM) and tandem mass spectrometry (MS) measurements for high-
throughput, virtually sample-prep free, protein structure measurements. The overall objective for this exploratory
project, which is the next step toward attaining our long-term goal, is to implement rapid ion/ion cross-linking
reactions on an IM/MS platform, using tandem mass spectrometry to identify cross-linked sites. The rationale for
the development of this technology is to combine the information from native IM/MS with information obtained
from cross-linking in an experimental method conducted on the sub-second timescale. The increase in
throughput, information, and lack of sample prep (compared to, e.g., X-ray diffractometry, nuclear magnetic
resonance, or cryo-electron microscopy) is expected to advance biomedical research determining protein
structure and function to where protein structural determinations can become rapid and routine. The overall
objective of this application will be reached through the following Specific Aims: 1. Combine gas-phase ion/ion
cross-linking of intact proteins with IM/MS measurements; and 2. Use IM combined with tandem MS to determine
cross-linking locations for intact proteins. For the first aim, a variety of monomeric and multimeric proteins will be
cross-linked in the gas-phase. Changes in overall structure between cross-linked and unmodified proteins, as
well as between solution and gas-phase cross-linked proteins, will be measured by IM. Under the second aim,
a combination of collision induced dissociation (CID) and electron capture dissociation (ECD) will be used to
determine cross-linked sites. The proposed technology is innovative because it represents a substantive
departure from the status quo by coupling cross-linking and native IM/MS analysis into one gas-phase mass
spectrometry experiment, allowing rapid cross-linking analysis and providing multiple complementary measures
of gas-phase protein structure. This new technology is significant because it is expected to become a rapid tool
for high-throughput characterization of primary, secondary, tertiary, and quaternary protein structure. When fully
developed, the technology has the potential to be used for complex mixtures of intact proteins and for rapid
screening of interactions with small molecules/drugs, creating new opportunities in clinical research, treatment,
and drug design.
项目摘要
尽管存在许多用于研究蛋白质结构的技术,但没有一个速度组合
选择性,准确性,分辨率和灵活性。长期目标是使用一套气相化学套件进行
离子/离子反应与离子迁移率(IM)和串联质谱法(MS)测量相关的离子/离子反应。
吞吐量,几乎没有样品-PREP的蛋白质结构测量。探索性的总体目标
项目是实现我们的长期目标的下一步,是实施快速离子/离子交联
IM/MS平台上的反应,使用串联质谱法识别交联位点。理由
该技术的开发是将来自本机IM/MS的信息与获得的信息相结合
从在亚秒时间尺度上进行的实验方法的交联。增加
吞吐量,信息和样品准备不足(与X射线衍射法相比,核磁性
共振或冷冻电子显微镜)有望推进生物医学研究确定蛋白质
蛋白质结构测定可以成为迅速和常规的结构和功能。总体
该应用的目的将通过以下特定目的达到:1。结合气相/离子离子
与IM/MS测量值的完整蛋白质交联;和2。使用IM与串联MS合并来确定
完整蛋白质的交联位置。对于第一个目标,各种单体和多聚蛋白将是
在气相中交联。交联蛋白质和未修饰的蛋白质之间的总体结构变化,AS
以及在溶液和气相交联蛋白之间,将通过IM测量。在第二个目标下,
碰撞诱导解离(CID)和电子捕获解离(ECD)的组合将用于
确定交联位点。提出的技术具有创新性,因为它代表了实质性
通过将交联和本机IM/MS分析耦合到一个气相质量,从现状偏离现状
光谱实验,允许快速交联分析并提供多种互补措施
气相蛋白结构。这项新技术很重要,因为它有望成为快速工具
用于高通量,次级,第三和第四纪蛋白结构的高通量表征。完全
该技术开发的潜力有可能用于完整蛋白质的复杂混合物,并用于快速
筛选与小分子/药物的相互作用,在临床研究,治疗中创造了新的机会,
和药物设计。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Ian Webb的其他基金
Intrinsically Disordered Protein Structural Dynamics from Combined Solution and Gas-Phase Approaches
结合溶液和气相方法的本质无序蛋白质结构动力学
- 批准号:1071489610714896
- 财政年份:2023
- 资助金额:$ 20.7万$ 20.7万
- 项目类别:
相似国自然基金
胃肠道微生物宏基因组的氨基酸消旋酶挖掘及分析
- 批准号:32360034
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
甘油制α-氨基酸钌基双金属催化剂的构筑及产物调控策略
- 批准号:22308255
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
射频协同纳他霉素干扰氨基酸转运高效杀灭黑曲霉的分子机制研究
- 批准号:32302279
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
αKG-NHFe酶FtmOx1通过氨基酸多重构象变化催化内过氧化反应的机理研究
- 批准号:22307037
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
18F-TZA分子探针靶向识别胶质瘤IDH1突变及其与氨基酸转运体的关联研究
- 批准号:82302337
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
- 批准号:1067834110678341
- 财政年份:2023
- 资助金额:$ 20.7万$ 20.7万
- 项目类别:
Role of mitochondrial GDAP1 in Alzheimer's disease
线粒体 GDAP1 在阿尔茨海默病中的作用
- 批准号:1073985810739858
- 财政年份:2023
- 资助金额:$ 20.7万$ 20.7万
- 项目类别:
Dissecting connections between diet, the microbiome and Alzheimers disease
剖析饮食、微生物组和阿尔茨海默病之间的联系
- 批准号:1074005610740056
- 财政年份:2023
- 资助金额:$ 20.7万$ 20.7万
- 项目类别:
Diagnostic aptamer reagents to develop multi-analyte blood test for pre-clinical, mild and moderate Alzheimer's disease
诊断适体试剂用于开发针对临床前、轻度和中度阿尔茨海默病的多分析物血液检测
- 批准号:1059784010597840
- 财政年份:2023
- 资助金额:$ 20.7万$ 20.7万
- 项目类别:
Molecular analysis of SORL1 function and dysfunction in Alzheimer's disease
阿尔茨海默病中 SORL1 功能和功能障碍的分子分析
- 批准号:1066115910661159
- 财政年份:2023
- 资助金额:$ 20.7万$ 20.7万
- 项目类别: